Daptomycin FDA Link

A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.

Also Known As:

Cubicin; Daptomycin, 9-L beta-Aspartic Acid; Deptomycin; LY-146032; Daptomycin, 9 L beta Aspartic Acid; LY 146032; LY146032; N- decanoyl- L- tryptophyl- L- asparaginyl- L- aspartyl- L- threonylglycyl- L- ornithyl- L- aspartyl- D- alanyl- L- aspartylglycyl- D- seryl- threo- 3- methyl- L- glutamyl- 3- anthraniloyl- L- alanine- epsilon1- lactone

Pharmalogical Action Categories:

Anti-Bacterial Agents

Polycyclic Compounds: 7
- Macrocyclic Compounds: 16
  - Cyclic Peptides: 558
    - Daptomycin: 1747
Lipids: 118169
- Lipopeptides: 647
  - Daptomycin: 1747
Amino Acids, Peptides, and Proteins: 1
- Peptides: 84029
  - Lipopeptides: 647
    - Daptomycin: 1747
  - Cyclic Peptides: 558
    - Daptomycin: 1747

Henrik Peisker Selected Research

Henrik Peisker Research Topics

Disease

Drug/Important Bio-Agent (IBA)